Reagents and models for detecting endogenous GLP1R and GIPR
Glucagon-like peptide-1 receptor (GLP1R) agonists target the GLP1R, whereas dual GLP1R/ gastric inhibitory polypeptide receptor (GIPR) agonists target both the GLP1R and GIPR. Despite the importance of these drug classes for the treatment of diabetes and obesity, still very little is known about the...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2021-12-01
|
| シリーズ: | EBioMedicine |
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S2352396421005338 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|